Loading data
NGNENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 925 k USD | 0 USD | — | — |
| Research and development expense | 75.01 m USD | 60.92 m USD | 44.39 m USD | 47.51 m USD | 39.16 m USD |
| Operating profit | -103.33 m USD | -82.61 m USD | -55.58 m USD | -56.52 m USD | -60.7 m USD |
| Interest expense | — | — | 12 k USD | 2 k USD | — |
| Profit before tax | -90.35 m USD | -75.14 m USD | -36.32 m USD | -55.19 m USD | -60.69 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -90.35 m USD | -75.14 m USD | -36.32 m USD | -60.69 m USD | -60.69 m USD |
| Basic earnings per share | -4.24 USD/share | -4.28 USD/share | — | -1.04 USD/share | -1.1 USD/share |
| Diluted earnings per share | -4.24 USD/share | -4.28 USD/share | — | -1.04 USD/share | -1.1 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.